Cited by 183Probiotics and Fermented FoodsGut microbiota and healthGastrointestinal motility and disorders

Probiotics for gastrointestinal symptoms and quality of life in autism: a placebo-controlled pilot trial

Open access
Arnold, L. Eugene, Luna, Ruth Ann, Williams, Kent, Chan, James, Parker, Robert A., Wu, Qinglong, Hollway, Jill A., Jeffs, Adelina +4 more·2019·Journal of Child and Adolescent Psychopharmacology

Abstract

Objective: A randomized pilot trial of gastrointestinal (GI) symptoms targeting probiotic for quality of life in autism spectrum disorder (ASD). Methods: Thirteen children, 3–12 years of age with ASD, anxiety, and GI symptoms, were randomized into a probiotic crossover trial of 8 weeks each on VISBIOME and placebo separated by a 3-week washout. VISBIOME contains eight probiotic species, mostly Lactobacillus and Bifidobacterium. Primary outcome was the Pediatric Quality of Life Inventory (PedsQL) GI module. Secondary outcomes included gut microbiota analysis, the Parent-Rated Anxiety Scale for ASD (PRAS-ASD), and parent-selected target symptoms. A mixed analysis model was applied. Results: Thirteen children were randomized, with 10 completing the study (77% retention): 6 in probiotic/placebo sequence, 4 in placebo/probiotic sequence. Adherence to study treatment was 96%. There were no serious adverse events (AEs), and more nonserious AEs occurred with placebo than with probiotic, including those attributable to treatment. Only 6 of the 10 guessed the correct treatment at the end of week 8. Over the 19-week trial, each outcome improved from baseline and PedsQL correlated significantly with abundance of Lactobacillus without discernable changes to microbiota composition/diversity. Although probiotic showed more improvement than placebo, PedsQL and PRAS-ASD were not statistically significant, as expected at this sample size. PedsQL effect size was d = 0.49 by the general model and d = 0.79 by simple comparison of week 8 changes. A parent-selected target symptom showed significant improvement in GI complaints on probiotic compared with placebo (p = 0.02, d = 0.79). Probiotic effects carried over through the 3-week washout. Conclusion: The VISBIOME formulation was safe and suggested a health benefit in children with ASD and GI symptoms who retained Lactobacillus. The moderate effect size compared with placebo warrants a larger trial using a parallel-group design.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/cap.2018.0156

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Anecdotal reports of behavioral improvements following effective treatment for GI problems exist, but prospective studies are still required.

    “Although there are anecdotal reports of behavioral improvements following effective treatment for GI problems, prospective studies are still required 7475.”

    From Gastrointestinal Issues and Autism Spectrum Disorder (2020) · cites this paper as [74]

  • In a small-randomized pilot trial of probiotics in children with ASD and GI problems, a probiotic mixture of eight Lactobacillus and Bifidobacterium species was given for the 19-week trial period.

    “Recently, a small-randomized pilot trial of probiotics in children with ASD and GI problems was conducted. A probiotic mixture of eight Lactobacillus and Bifidobacterium species was given for the 19-week trial period.”

    From Gastrointestinal Issues and Autism Spectrum Disorder (2020) · cites this paper as [74]

  • In that trial, parents reported a significant improvement in GI symptoms, but the overall resulting quality of life measures were not significant.

    “Although parents reported a significant improvement in GI symptoms, the overall resulting quality of life measures were not significant 74.”

    From Gastrointestinal Issues and Autism Spectrum Disorder (2020) · cites this paper as [74]

  • Anecdotal reports suggest that effective treatment of GI disorders is important not only for attenuation of GI problems but potential improvements in associated behavioral correlates.

    “These anecdotal reports, however, suggest that effective treatment of GI disorders is important not only for the attenuation of the GI problems, but potential improvements in associated behavioral correlates as well 747677.”

    From Gastrointestinal Issues and Autism Spectrum Disorder (2020) · cites this paper as [74]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 7

  1. Abidin RR: Parenting Stress Index—Short Form (3rd ed.). Odessa, FL, Psychological Assessment Resources, Inc., 1995 [Google Scholar]
  2. Abidin RR: Parenting Stress Index Manual (4th ed.). Odessa, FL, Psychological Assessment Resources, 2012 [Google Scholar]
  3. Constantino JN: Social Responsiveness Scale. Los Angeles, CA, Western Psychological Services, 2012 [Google Scholar]
  4. Lord C, Rutter M, DiLiavore PC, Risi S, Gotham K. Autism Diagnostic Observation Schedule 2. Los Angeles, CA: Western Psychological Services, ABC, 2012 [Google Scholar]
  5. Scahill L: Development and Testing of Parent-Rated Anxiety Scale for Youth with ASD. Oral presentation at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington, DC, October 25, 2017 [Google Scholar]
  6. West R, Roberts E, Sichel LS, Sichel J: Improvements in gastrointestinal symptoms among children with autism spectrum disorder receiving the Delpro® probiotic and immunomodulator formulation. J Probiotics Health 1:102, 2013 [Google Scholar]
  7. WHO: Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, a Joint FAO/WHO Expert Consultation. Cordoba Argentina, October 1–4, 2001. WHO, 2003. www.who.int/foodsafety/publications/fs_management/probiotics/en Accessed November15, 2003 [Google Scholar]

Cited by

Sorted by citations

Authors
Arnold, L. E., Luna, R. A., Williams, K., Chan, J., Parker, R. A., Wu, Q., Hollway, J. A., Jeffs, A., Lu, F., Coury, D. L., Hayes, C., & Savidge, T.
Affiliations
  • The Ohio State University (US)
  • Baylor College of Medicine (US)
  • Nationwide Children's Hospital (US)
  • Massachusetts General Hospital (US)
Corresponding author
Arnold, L. Eugene
Venue
Journal of Child and Adolescent Psychopharmacology
Published
2019-11-01
Volume
29
Issue
9
Pages
659-669
ISSN
  • 1044-5463 (ISSN-L)
  • 1557-8992
OpenAlex
W2972209545
Cited by
183
References
50
Citations by year
2026: 21 · 2025: 34 · 2024: 26 · 2023: 27 · 2022: 45 · 2021: 14 · 2020: 15
FWCI
14.27
Type
journal article
Language
en
Open access
Locations
  • Journal of Child and Adolescent Psychopharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Autism Speaks
  • Ohio State University
  • Supernus Pharmaceuticals
  • Health Resources and Services Administration
  • Pfizer Pharmaceuticals
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
probiotics, autism spectrum disorder, gastrointestinal symptoms, quality of life, anxiety, Lactobacillus, Bifidobacterium, gut microbiota, pediatric patients, crossover design
MeSH terms
Autism Spectrum Disorder, Child, Child, Preschool, Female, Humans, Male, Pilot Projects, Placebos, Quality of Life, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review